Showing results (1931-1940 of 2,171) with videos related to
Sort By:
Pageof 218
Journal of the American College of Cardiology|February 21, 2004
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trialHitinder S Gurm, A Michael Lincoff, David Lee, et al.American Heart Journal|February 9, 2002
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network TrialKenneth W Mahaffey, Matthew T Roe, Christopher K Dyke, et al.American Heart Journal|February 14, 2025
Pharmaco-invasive strategy and dosing of tenecteplase in STEMI patients 60 to <75 years: An inter-trial comparison of the STREAM-1 and STREAM-2 trialsKevin R Bainey, Robert C Welsh, Yinggan Zheng, et al.American Heart Journal|August 1, 2006
The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experienceShaun G Goodman, Yuling Fu, Anatoly Langer, et al.Journal of Cardiac Failure|July 3, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes ModelRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.Therapeutic Drug Monitoring|January 30, 2009
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conferencePierre Wallemacq, Victor W Armstrong, Merce Brunet, et al.European Journal of Heart Failure|December 15, 2015
Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudyAntonio L Perez, Justin L Grodin, Yuping Wu, et al.International Journal of Cardiology|July 17, 2012
Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trialRenato D Lopes, Jennifer A White, Pierluigi Tricoci, et al.European Journal of Heart Failure|October 31, 2017
Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HFMarat Fudim, Christopher M O'Connor, Allison Dunning, et al.Journal of the American College of Cardiology|May 21, 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trendsPierluigi Tricoci, Sergio Leonardi, Jennifer White, et al.Pageof 218